RIB - Biotechnologies
2005
Découverte de leads pharmaceutiques anti-cancéreux dirigés contre des protéines régulant la prolifération et l’apoptose – APTA
Project coordination
Divers privé
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partnership
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - ADR DE LYON - ADR 5
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE - ADR DE LYON - ADR 5
Help of the ANR 819,447 euros
Beginning and duration of the scientific project:
- 24 Months
